Circle Pharma is a biotechnology company creating bioavailable macrocyclic peptide therapeutics that target protein-protein interactions.
Circle Pharma has raised $90.0M in total funding. The most recent round was Series D. The last funding was announced in September 2024.
Circle Pharma's investors include Eli Lilly, Pfizer, The Column Group, Eli Lilly & Company Foundation, Lifeforce Capital.
Circle Pharma is headquartered in San Francisco, United States.
Circle Pharma is a biotechnology company creating bioavailable macrocyclic peptide therapeutics that target protein-protein interactions.
Circle Pharma is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Circle Pharma — Funding & Investors." VCBacked, September 3, 2024, https://www.vcbacked.co/company/circle-pharma. Accessed September 13, 2026.
VCBacked. (2024). Circle Pharma — Funding & Investors. Retrieved September 13, 2026, from https://www.vcbacked.co/company/circle-pharma
{{cite web |title=Circle Pharma — Funding & Investors |url=https://www.vcbacked.co/company/circle-pharma |website=VCBacked |access-date=September 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated